ABIOMED
Arrow International
Baxter Health Care Corporation
Boston Scientific Corporation SCIMED
CardioWest Technologies Inc.
Datascope Corporation
Institute for Biomedical Engineering
L-VAD Technology Inc.
McGowan Center for Artificial Organs
Medtronic Inc.
Senko Medical Instrument Mfg. Co., Ltd.
Terumo Cardiovascular Systems
Terumo R&D Center
Texas Heart Institute
Thermo Cardiosystems Inc.
Thoratec Laboratories Corporation
University of Michigan Extracorporeal Circulation Laboratory
University of Ottowa Heart Institute
University of Sao Paulo, Heart Institute, Bioengineering Division
University of Utah, Bioengineering Department
Utah Artificial Heart Institute
Vitagen Incorporated
|
 |
CardioWest Technologies Inc. |
| |
 |
1501 North Campbell Ave., Room 4607 Tucson, Arizona 85724 |
 |
(520) 694-5200 |
 |
|
 |
www.cardiowest.org |
| |
 |
Steve Langford, General Manager |
 |
|
| |
 |
|
| |
 |
CardioWest Technologies Inc. is the manufacturer and distributor of the total artificial heart (TAH). The CardioWest C-70 TAH is a pneumatic, implantable system that completely replaces a failing heart. It has been used all over the world as a bridge-to-transplant device in 162 patients. The CardioWest (CWT) heart is the direct descendant of the Jarvik heart, developed at the University of Utah and first implanted in 1982 in Barney Clark as a permanent replacement heart. The Symbion heart followed. It was first used successfully to keep a patient alive for a transplant in 1985, and 198 patients were implanted before the U.S. Food and Drug Administration (FDA) halted all use of the Jarvik in January of 1990 because of record-keeping and quality-control problems. Later the same year in September, the company began negotiating the sale of its technology and assets to CWT. The technology was all but lost except for the involvement of the University Medical Center (UMC) and the MedForte Research Foundation. In 1991, these two entities formed a new corporation and joint venture, CardioWest Technologies Inc. The principal investigator in a nationwide study of the CWT C-70 TAH is the world-renowned cardiothoracic surgeon Jack Copeland, M.D. |
| |
|
| |
Collections
|
 |
[Additional information on collections forthcoming] |
| |
 |
|
| |
 |
|
| |
 |
|
| |
 |
|
| |
 |
|
| |
 |
|
| |
 |
|
|
